EIR Sattva S. Neelapu, M.D. Jul 2017

Mark Babbitt FDA$595.00 - Available Now

FDA investigators audited the Sattva S. Neelapu, M.D. - Houston, TX, United States facility and issued inspectional observation (via FDA 483) on 28 Jul 2017.

Product details

  • Category:
  • Inspection end: 28 Jul 2017
  • Location: Houston, United States
  • FEI: 3013623579
Add To Cart